Correlation Between GeneThera and Medigene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GeneThera and Medigene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GeneThera and Medigene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GeneThera and Medigene AG, you can compare the effects of market volatilities on GeneThera and Medigene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GeneThera with a short position of Medigene. Check out your portfolio center. Please also check ongoing floating volatility patterns of GeneThera and Medigene.

Diversification Opportunities for GeneThera and Medigene

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GeneThera and Medigene is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding GeneThera and Medigene AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigene AG and GeneThera is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GeneThera are associated (or correlated) with Medigene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigene AG has no effect on the direction of GeneThera i.e., GeneThera and Medigene go up and down completely randomly.

Pair Corralation between GeneThera and Medigene

Given the investment horizon of 90 days GeneThera is expected to under-perform the Medigene. But the pink sheet apears to be less risky and, when comparing its historical volatility, GeneThera is 1.46 times less risky than Medigene. The pink sheet trades about -0.06 of its potential returns per unit of risk. The Medigene AG is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  155.00  in Medigene AG on September 14, 2024 and sell it today you would earn a total of  104.00  from holding Medigene AG or generate 67.1% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy72.49%
ValuesDaily Returns

GeneThera  vs.  Medigene AG

 Performance 
       Timeline  
GeneThera 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GeneThera has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable technical indicators, GeneThera is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Medigene AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medigene AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Medigene is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

GeneThera and Medigene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GeneThera and Medigene

The main advantage of trading using opposite GeneThera and Medigene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GeneThera position performs unexpectedly, Medigene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigene will offset losses from the drop in Medigene's long position.
The idea behind GeneThera and Medigene AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.